Lack of interaction between LRP1 and A2M polymorphisms for the risk of Alzheimer disease

Neuroscience Letters

Volumn 482, Issue 2, 2010, Pages 112-116

  Bruno, Elisa ^a   Quattrocchi, Graziella ^a   Nicoletti, Alessandra ^a   Le Pira, Francesco ^a   Maci, Tiziana ^a   Mostile, Giovanni ^a   Andreoli, Virginia ^b   Quattrone, Aldo ^c   Zappia, Mario ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Alzheimer disease; Epidemiology; Genetic

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 77955773912     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.07.012     Document Type: Article

References (37)

1. Appollonio I., Leone M., Isella V., Piamarta F., Consoli T., Villa M., Forapani E., Russo A., Nichelli P. The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol. Sci. 2005, 26:108-116.
2. Bian L., Yang J.D., Guo T.W., Duan Y., Qin W., Sun Y., Feng G.Y., He L. Association study of the A2M and LRP1 genes with Alzheimer disease in the Han Chinese. Biol. Psychiatry 2005, 58:731-737.
3. Caltagirone C., Gainotti G., Masullo C., Miceli G. Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychiatr. Scand. 1979, 60:50-56.
4. Carlesimo G.A., Caltagirone C., Gainotti G., Fadda L., Gallassi R., Lorusso S., Marfia G., Marra C., Nocentini U., Parnetti L. The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. Eur. Neurol. 1996, 36:378-384.
5. Colacicco A.M., Solfrizzi V., D'Introno A., Capurso C., Kehoe P.G., Seripa D., Pilotto A., Santamato A., Capurso A., Panza F. Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease. Neurobiol. Aging 2009, 30:1518-1520.
6. Corder E.H, Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
7. Depboylu C., Lohmüller F., Du Y., Riemenschneider M., Kurz A., Gasser T., Müller U., Dodel R.C. Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease. Neurosci. Lett. 2006, 400(3):187-190.
8. Dodel R.C, Du Y., Bales K.R., Gao F., Eastwood B., Glazier B., Zimmer R., Cordell B., Hake A., Evans R., Gallagher-Thompson D., Thompson L.W., Tinklenberg J.R., Pfefferbaum A., Sullivan E.V., Yesavage J., Alstiel L., Gasser T., Farlow M.R., Murphy G.M., Paul S.M. Alpha2 macroglobulin and the risk of Alzheimer's disease. Neurology 2000, 54(2):438-442.
9. D'Introno A., Solfrizzi V., Colacicco A.M., Capurso C., Amodio M., Todarello O., Capurso A., Kehoe P.G., Panza F. Current knowledge of chromosome 12 susceptibility genes for late-onset Alzheimer's disease. Neurobiol. Aging 2006, 27:1537-1553.
10. Dubois B., Slachevsky A., Litvan I., Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000, 55:1621-1626.
11. Folstein M.F., Folstein S.E., McHugh P.R. Mini Mental State Examination: a practical method for grading the cognitive state of patients for the clinicians. J. Psychiatr. Res. 1975, 12:189-198.
12. Gainotti G., Marra C., Villa G. A double dissociation between accuracy and time of execution on attentional tasks in Alzheimer's disease and multi-infarct dementia. Brain 2001, 124:731-738.
13. Hollenbach E., Ackermann S., Hyman B.T., Rebeck G.W. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology 1998, 50:1905-1907.
14. Jaeger L.B., Dohgu S., Hwang M.C., Farr S.A., Murphy M.P., Fleegal-DeMotta M.A., Lynch J.L., Robinson S.M., Niehoff M.L., Johnson S.N., Kumar V.B., Banks W.A. Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. J. Alzheimers Dis. 2009, 17(3):553-570.
15. Kang D.E, Saitoh T., Chen X., Xia Y., Masliah E., Hansen L.A., Thomas R.G., Thal L.J., Katzman R. Genetic association of the low density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 1997, 49:56-61.
16. Kehoe P., Wavrant-De Vrieze F., Crook R., Wu W.S., Holmans P., Fenton I., Spurlock G., Norton N., Williams H., Williams N., Lovestone S., Perez-Tur J., Hutton M., Chartier-Harlin M.C., Shears S., Rohel K., Booth J., Van Vroost W., Ramic D., Williams J., Goate A., Hardy J., Owen M.J. A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet. 1999, 8:237-245.
17. Lavarone A., Ronga B., Pellegrino L., Loré E., Vitaliano S., Galeone F., Carlomagno S. The frontal assessment battery (FAB): normative data from an Italian sample and performance of patients with Alzheimer's disease and frontotemporal dementia. Funct. Neurol. 2004, 19(3):191-195.
18. Llorca J., Rodríguez-Rodríguez E., Dierssen-Sotos T., Delgado-Rodríguez M., Berciano J., Combarros O. Meta-analysis of genetic variability in the beta-amyloid production, aggregation and degradation metabolic pathways and the risk of Alzheimer's disease. Acta Neurol. Scand. 2008, 117(1):1-14.
19. Matthijs G, Marynen I. A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene. Nucleic Acids Res. 1991, 19:5102.
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34(7):939-944.
21. Measso G., Cavarzeran F., Zappala G., Lebowitz B.D., Crook T.H., Pirozzolo F.J., Amaducci L.A., Massari D., Grigoletto F. The Mini Mental State Examination: studio normative di un campione random della popolazione italiana. Dev. Neuropsychol. 1993, 77-85.
22. Nacmias B., Tedde A., Cellini E., Forleo P., Orlacchio A., Guarnieri B.M., Petruzzi C., D'Andrea F., Serio A., Sorbi S. Alpha2 macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease. Neurosci. Lett. 2001, 299:9-12.
23. Oliveri R.L., Cittadella R., Sibilia G., Manna I., Valentino P., Gambardella A., Aguglia U., Zappia M., Romeo N., Andreoli V., Bono F., Caracciolo M., Quattrone A. APOE and risk of cognitive impairment in multiple sclerosis. Acta Neurol. Scand. 1999, 100:290-295.
24. Panza F., D'Introno A., Colacicco A.M., Capurso C., Basile A.M., Capurso S., Capurso A., Solfrizzi V. Regional European differences in allele and genotype frequencies of low density lipoprotein receptor-related protein1 polymoprhism in Alzheimer's disease. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2004, 126:69-73.
25. Panza F., Colacicco A.M., D'Introno A., Capurso C., Liaci M., Capurso S.A., Capurso A., Solfrizzi V. Candidate genes for late-onset Alzheimer's disease: focus on chromosome 12. Mech. Ageing Dev. 2006, 127:36-47.
26. Pericak-Vance M.A., Bass M.P., Yamaoka L.H., Gaskell P.C., Scott W.K., Terwedow H.A., Menold M.M., Conneally P.M., Small G.W., Vance J.M., Saunders A.M., Roses A.D., Haines J.L. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 1997, 278(15):1237-1241.
27. Poller W., Faber J.P., Klobeck G., Olek K. Cloning of the human alpha 2-macroglobulin gene and detection of mutations in two functional domains: the bait region and the thiolester site. Hum. Genet. 1992, 88:313-319.
28. Rebeck G.W., Harr S.D., Strickland D.K., Hyman B.T. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 1995, 37(2):211-217.
29. Saunders A.J, Bertram I., Mullin K., Sampson A.J., Latifzai K., Basu S., Jones J., Kinney D., MacKenzie-Ingano L., Yu S., Albert M.S., Moscarillo T.J., Go R.C., Bassett S.S., Daly M.J., Laird N.M., Wang X., Velicelebi G., Wagner S.L., Becker D.K., Tanzi R.E., Blacker D. Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin. Hum. Mol. Genet. 2003, 12:2765-2776.
30. Scott W.K., Grubber J.M., Conneally P.M., Small G.W., Hulette C.M., Rosenberg C.K., Saunders A.M., Roses A.D., Haines J.L., Pericak-Vance M.A. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. Am. J. Hum. Genet. 2000, 66:922-932.
31. Stata Corp. STATA statistical software: release 10.0. STATA Corporation, College station, TX, USA, 2007.
32. Rodriguez S., Gaunt T.R., Day I.N. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am. J. Epidemiol. 2009, 169:505-514.
33. Verpillat P., Bouley S., Campion D., Hannequin D., Dubois B., Belliard S., Puel M., Thomas-Anterion C., Agid Y., Brice A., Clerget-Darpoux F. Use of haplotype information to test involvement of the LRP gene in Alzhiemer's disease in the French population. Eur. J. Hum. Genet. 2001, 108:105-108.
34. Wavrant-DeVrieze F., Rudrasingham V., Lambert J.C., Chakraverty S., Kehoe P., Crook R., Amouyel P., Wu W., Holmans P., Rice F., Perez-Tur J., Frigard B., Morris J.C., Carty S., Cottel D., Tunstall N., Lovestone S., Petersen R.C., Chartier-Harlin M.C., Goate A., Owen M.J., Williams J., Hardy J. No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. Neurosci. Lett. 1999, 262:137-139.
35. Wu W.S., Holmans P., Wavrant-De Vrieze F., Shears S., Kehoe P., Crook R., Booth J., Williams N., Perez-Tur J., Rohel K., Fenton I., Chartier-Harlin M.C., Lovestone S., Williams J., Hutton M., Hardy J., Owen M.J., Goate A. Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA 1998, 280:619-622.
36. Zappia M., Cittadella R., Manna I., Nicoletti G., Andreoli V., Bonavita S., Gambardella A., Quattrone A. Genetic association of alpha2-macroglobulin polymorphisms with AD in southern Italy. Neurology 2002, 59(5):756-758.
37. Zappia M., Manna I., Serra P., Cittadella R., Andreoli V., La Russa A., Annesi F., Spadafora P., Romeo N., Nicoletti G., Messina D., Gambardella A., Quattrone A. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms. Arch. Neurol. 2004, 61(3):341-344.